Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Atlas Arteria ( (AU:ALX) ) just unveiled an announcement.
Atlas Arteria has disclosed a change in the interests of director Hugh Wehby following the issuance of additional equity-based incentives. The filing details that Wehby holds his stapled securities indirectly through the company’s employee share plan manager, with Solium Nominees acting as registered holder under an allocated account structure.
Wehby received 228,381 restricted stapled securities under Atlas Arteria’s 2025 short-term incentive plan and 462,284 performance rights under the 2026 long-term incentive plan, both recently approved by securityholders at the May annual meeting. The grants, issued for nil cash consideration but carrying a market value reference of $4.81 per stapled security, significantly increase his exposure to the company and further align executive remuneration with investor outcomes.
The most recent analyst rating on (AU:ALX) stock is a Hold with a A$4.80 price target. To see the full list of analyst forecasts on Atlas Arteria stock, see the AU:ALX Stock Forecast page.
More about Atlas Arteria
Atlas Arteria is a listed infrastructure company that invests in and manages toll road and related transport assets. Its stapled securities structure combines Atlas Arteria Limited and Atlas Arteria International Limited, giving investors exposure to a portfolio of roadway concessions in various markets. The group focuses on long-term, cash-generating transport infrastructure with stable demand dynamics.
Average Trading Volume: 3,075,277
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$6.98B
For detailed information about ALX stock, go to TipRanks’ Stock Analysis page.